PATENT CLAIM ANALYSIS

Application Number: 16044320
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["546", "268100"]

Abstract:
The invention relates to a compound of formula (I) wherein A and R 1  to R 4  are defined as in the description and in the claims. The compound of formula (I) can be used as a medicament.

Claim (Index 13):
A method for the treatment or prophylaxis of pain, neuropathic pain, asthma, osteoporosis, inflammation, psychiatric diseases, psychosis, oncology, encephalitis, malaria, allergy, immunological disorders, arthritis, gastrointestinal disorders, psychiatric disorders rheumatoid arthritis, psychosis or allergy, comprising administering to a patient in need thereof an effective amount of the compound of  claim 1 , or a pharmaceutically acceptable salt thereof.

Metadata:
- Claim Count in Document: 32.0
- Percentile: 95.0
- Lexical Diversity: 1.51724
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14868305', '15050753', '14648418', '13486057', '15478435']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8076986534726256
- 35 USC 102 Novelty (BERT): 0.5378403012801712
- Combined Prediction Score: 0.7807128182533802
- Mean Citation Score: 374.275046
- Max Citation Score: 408.03818
- Similarity Product: 266.33102230628253

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test